Skip to content

Medical Clowning in the NICU (Neonatal Intensive Care Unit and Their Effects on Parents and Staff

Effects of Medical Clowning (Dream Doctors) on the Development of the Nervous System and the Relationship Between Preterm Premature Baby Parents and NICU Staff

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02048202
Acronym
clowns
Enrollment
60
Registered
2014-01-29
Start date
2014-01-31
Completion date
2016-01-31
Last updated
2015-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Neonate

Keywords

clown, neonate, premature

Brief summary

The study will compare intervention by Infant Aquatics to infant massage. The intervention in both methods will start at 36 weeks gestational age for 3 months and will consist of sessions with a therapist every 2 weeks. Development will be assessed and compared at 3, 8 and 18 months using Infant Motor Pattern method, Griffith developmental scales and Vineland adaptive behavior scales.

Detailed description

Preterm infants, a continuously growing population, are at high risk for neurodevelopment impairments ranging from minor neurological dysfunction (MND) to cerebral palsy (CP), mainly due to developmental brain injury. Infant Aquatics have been found to benefit and promote infant development. The support and sensory stimulation of the water may improve the development the sensory, motor, as well as, autonomic system of preterm infants.

Interventions

None listed

Sponsors

University of Haifa
CollaboratorOTHER
The Baruch Padeh Medical Center, Poriya
Lead SponsorOTHER_GOV

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Weeks
Healthy volunteers
No

Inclusion criteria

* neonates wherein their parents have expressed consent to participate in trail * neonates with parents who are able to understand and fill in questioners * neonates with no chromosomal deficiencies and no genetic deficiency

Exclusion criteria

* neonates with parents who are unable to understand and fill in questioners * neonates with intraventricular bleeding IVH/PVH * neonates with periventricular hemorrhage * neonates with known chromosomal deficiencies or genetic deficiency

Design outcomes

Primary

MeasureTime frame
◦Developmental assessment - a composite of several measures◦Time Frame: 3 month

Secondary

MeasureTime frameDescription
Developmental assessment - a composite of several measures◦◦Time Frame: 18 monthSafety Issue?: No

Countries

Israel

Contacts

Primary ContactShay Barak, MD
sbarak@poria.health.gov.il050-6267496
Backup ContactHagit Friedman, PhD
hmts@netvision.net.il050-6267427

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026